A comprehensive urinary metabolomic approach for identifying kidney cancer

被引:370
作者
Kind, Tobias
Tolstikov, Vladimir
Fiehn, Oliver
Weiss, Robert H. [1 ]
机构
[1] Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA
[2] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA
[3] No Calif Hlth Care Syst, Dept Vet Affairs, Sacramento, CA 95655 USA
关键词
metabolomics; kidney cancer; urine analysis; chromatography; mass spectrometry;
D O I
10.1016/j.ab.2007.01.028
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The diagnosis of cancer by examination of the urine has the potential to improve patient outcomes by means of earlier detection. Due to the fact that the urine contains metabolic signatures of many biochemical pathways, this biofluid is ideally suited for metabolomic analysis, especially involving diseases of the kidney and urinary system. In this pilot study, we test three independent analytical techniques for suitability for detection of renal cell carcinoma (RCC) in urine of affected patients. Hydrophilic interaction chromatography (HILIC-LC-MS), reversed-phase ultra performance liquid chromatography (RP-UPLC-MS), and gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) all were used as complementary separation techniques. The combination of these techniques is best suited to cover a very large part of the urine metabolome by enabling the detection of both lipophilic and hydrophilic metabolites present therein. In this study, it is demonstrated that sample pretreatment with urease dramatically alters the metabolome composition apart from removal of urea. Two new freely available peak alignment methods, MZmine and XCMS, are used for peak detection and retention time alignment. The results are analyzed by a feature selection algorithm with subsequent univariate analysis of variance (ANOVA) and a multivariate partial least squares (PLS) approach. From more than 2000 mass spectral features detected in the urine, we identify several significant components that lead to discrimination between RCC patients and controls despite the relatively small sample size. A feature selection process condensed the significant features to less than 30 components in each of the data sets. In future work, these potential biomarkers will be further validated with a larger patient cohort. Such investigation will likely lead to clinically applicable assays for earlier diagnosis of RCC, as well as other malignancies, and thereby improved patient prognosis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 32 条
  • [1] BENIJTS T, 2006, RADIP COMMUN MASS SP, V17, P1866
  • [2] Dettmer K, 2004, ENVIRON HEALTH PERSP, V112, pA396
  • [3] Metabolomics: Current analytical platforms and methodologies
    Dunn, WB
    Ellis, DI
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2005, 24 (04) : 285 - 294
  • [4] EVENSON MA, 1979, ANAL CHEM, V51, pR35
  • [5] FIEHN O, 2006, BIOINFORMATICS, V3615, P224
  • [6] Friedman LawrenceM., 1998, Fundamentals of Clinical Trials, VThird
  • [7] Vitamin E as a protective antioxidant in progressive renal failure
    Fryer, MJ
    [J]. NEPHROLOGY, 2000, 5 (1-2) : 1 - 7
  • [8] Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma
    Han, WK
    Alinani, A
    Wu, CL
    Michaelson, D
    Loda, M
    McGovern, FJ
    Thadhani, R
    Bonventre, JV
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04): : 1126 - 1134
  • [9] Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry
    Idborg, H
    Zamani, L
    Edlund, PO
    Schuppe-Koistinen, I
    Jacobsson, SP
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 828 (1-2): : 9 - 13
  • [10] JAIN AK, 2006, IEEE T PATTERN ANAL, V22, P4